NEW YORK, Nov 27 – Aclara BioSciences said that a trial judge has granted the company’s request to reduce a $52 million jury award in a microfluidics trade secret lawsuit with Caliper Technologies by $17 million .
“In addition, we intend to appeal the remaining $35 million and believe that we have strong grounds on which to base that appeal," Joseph Limber, president and CEO of Aclara said in a statement released Sunday.
The award will be stayed, with no payment to Caliper, until the appeal is resolved, Aclara said.
The Court has not ruled on Caliper's request for a constructive trust. Once the Court rules on equitable relief and enters a judgment, Aclara expects to file an appeal to the California Court of Appeal for the Sixth Appellate District. The company expects the appeal to be heard within a year.
As of mid-August Aclara reported assets in excess of $210 million.